GENE POSSIBILITIES

Serial Number 97232101
Registration 7057119
700

Registration Progress

Application Filed
Jan 21, 2022
Under Examination
Jan 10, 2023
Approved for Publication
Nov 15, 2022
Published for Opposition
Nov 15, 2022
Registered
May 16, 2023

Trademark Image

GENE POSSIBILITIES

Basic Information

Serial Number
97232101
Registration Number
7057119
Filing Date
January 21, 2022
Registration Date
May 16, 2023
Published for Opposition
November 15, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
May 16, 2023
Registration
Registered
Classes
042 044

Rights Holder

Vertex Pharmaceuticals Incorporated

03
Address
50 Northern Avenue
Boston, MA 02210

Ownership History

Vertex Pharmaceuticals Incorporated

Original Applicant
03
Boston, MA

Vertex Pharmaceuticals Incorporated

Owner at Publication
03
Boston, MA

Vertex Pharmaceuticals Incorporated

Original Registrant
03
Boston, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Deadline
1245 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20230516)
Due Date
May 16, 2029
Grace Period Ends
November 16, 2029
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

22 events
Date Code Type Description Documents
May 16, 2023 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
May 16, 2023 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Apr 14, 2023 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Apr 13, 2023 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Feb 11, 2023 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jan 13, 2023 IUAF S USE AMENDMENT FILED Loading...
Feb 11, 2023 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jan 13, 2023 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Jan 10, 2023 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 15, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 15, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 26, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 7, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 15, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 14, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 14, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Aug 15, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Aug 15, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 8, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 26, 2022 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 25, 2022 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Providing medical and scientific research information in the field of gene editing
First Use Anywhere: May 2, 2022
First Use in Commerce: May 2, 2022
Class 044
Providing medical and healthcare information in the field of gene editing technology; Providing medical and healthcare information in the field of gene editing technology to health care professionals, to persons having genetic diseases, and to their caregivers
First Use Anywhere: May 2, 2022
First Use in Commerce: May 2, 2022

Classification

International Classes
042 044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"